CVR 42398993Private limited company (ApS)Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder (711210)CharlottenlundFounded 19 May 2021
Employees
1
CVR registry, Jun 2026
0 (0%) over 12 months
Revenue
2M
DKK, annual report 2026
+3.9% on 2025
Result
+432.1K
DKK, annual report 2026
Equity
474K
DKK, annual report 2026
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about JR Pharma Engineering ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexJR Pharma Engineering Holding ApSCVR 42396273, 100% of capital and votes, since 19 May 2021
Jimmy Rønne Jensensince 19 May 2021
CVR 42396273100% of capital and votessince 19 May 2021
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Ultimate controller
Holds 100% of capital and votes in JR Pharma Engineering Holding ApS, since 18 May 2021
Holding company
JR Pharma Engineering Holding ApS
CVR 42396273Private limited company (ApS)
Holds 100% of capital and votes in JR Pharma Engineering ApS, since 19 May 2021
This company
JR Pharma Engineering ApS
CVR 42398993
CVR records founders at incorporation. It does not record whether they are alive or still involved.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 1,482 | 1,866 | 1,960 | 1,926 | 2,000 |
| Operating profit | +738 | +828 | +843 | +759 | +555 |
| Result for the year | +573 | +645 | +651 | +592 | +432 |
| Equity | 615 | 687 | 693 | 634 | 474 |
| Total assets | 919 | 1,233 | 1,089 | 999 | 951 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | Not reportednote 1 | 25.9% | 5.1% | -1.7% | 3.9% |
| EBIT margin (overskudsgrad) | 49.8% | 44.4% | 43% | 39.4% | 27.7% |
| EBITDA | 744 | 853 | 844 | 770 | 555 |
| EBITDA margin | 50.2% | 45.8% | 43.1% | 40% | 27.7% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -388note 2 | -765note 2 | -668note 2 | -566note 2 | -506note 2 |
| Gearing, NIBD / EBITDA | Net cashnote 2 | Net cashnote 2 | Net cashnote 2 | Net cashnote 2 | Net cashnote 2 |
| ROIC (afkast af investeret kapital) | Not reportednote 1 | Not reportednote 3 | n.m.note 4 | 1,283.2%note 2 | 2,423.5%note 2 |
DKK thousands. Annual reports via XBRL. Not every period is a full year: 2022 covers 13 months (19 May 2021 to 30 Jun 2022). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2026
1 Jul 2025 to 30 Jun 2026, published 30 Aug 2026
Annual report 2025
1 Jul 2024 to 30 Jun 2025, published 29 Aug 2025
Annual report 2024
1 Jul 2023 to 30 Jun 2024, published 30 Sep 2024
Annual report 2023
1 Jul 2022 to 30 Jun 2023, published 18 Aug 2023
Annual report 2022
19 May 2021 to 30 Jun 2022, published 30 Dec 2022
1 registered in CVR.
P-number 1027177448Hyldegårds Tværvej 47, 2920 Charlottenlund
